Tech Company Financing Transactions
GenomeNext Funding Round
On 2/25/2016, GenomeNext announced $1.2 million in Seed funding from Hydra Capital and private investors.
Transaction Overview
Company Name
Announced On
2/25/2016
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Seed
Investors
Proceeds Purpose
The company intends to usr the funds to expand its commercial and operational capacity, and continue to develop its genomic analysis platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
175 South 3rd St. 200
Columbus, OH 43215
USA
Columbus, OH 43215
USA
Phone
Undisclosed
Website
Email Address
Overview
GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze, share and store genomic data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Hirmas
Chief Operating Officer
Chris Drescher
Chief Scientific Officer
Peter White
Browse more venture capital transactions:
Prev: 2/25/2016: NoBroker venture capital transaction
Next: 2/25/2016: OpenGamma venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs